Completed
A Phase I Imaging and Pharmacodynamic Trial of CS-1008 in Patients With Metastatic Colorectal Cancer
NCT01220999
- Conditions
- Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +8 more
- Locations
-
- Ludwig Institute Tumor Targeting Program, Austin Health Melbourne, Victoria, Australia